NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · MID CAP
Orasure Technologies, Inc. OSUR
17 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$115.0M
▼ 38.1% vs FY2024
EPS · FY25
$-0.94
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-18.3%
Net margin · FY25
-59.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 115.0M
Revenue, FY2025 · full 17-year series below
Revenue
Net income
The company lost 60 cents on every revenue dollar this year.
Per share
USD -0.94
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-18.3%
Return on equity, FY2025
ROE
Operating margin-62.6%
Net margin-59.8%
Return on assets-15.6%
Each USD of equity lost 18 cents this year.
Returned to shareholders
USD 15.0M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 15.0M
Share of profit-21.9%
Consecutive raises—
USD 15.0M in buybacks went back to shareholders in a year without profit.
Growth
−7.7% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−33.3%
−7.7%
−0.4%
+2.9%
Returned to shareholders
+88.7%
+10.2%
+22.7%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.07B
Shares outstanding, FY2025
Change, 5 years−1.9%
Change, 10 years+26.4%
The share count shrank 2% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 403.2M
total assets, end of FY2025
Total assetsUSD 403.2M
EquityUSD 340.8M
CashUSD 199.3M
Current ratio6.58×
Equity funds 85% of total assets.
History
17 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
Revenue $B
0.1
0.2
0.4
0.4
0.2
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
0.1
0.1
0.1
Operating income $B
−0.1
−0.0
0.0
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.1
−0.0
0.1
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
·
−0.0
Net income $B
−0.1
−0.0
0.1
−0.0
−0.0
−0.0
0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.94
−0.26
0.72
−0.24
−0.32
−0.22
0.27
0.33
0.51
0.35
0.14
−0.08
−0.20
−0.29
−0.19
−0.08
−0.17
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
−18.3
−4.6
13.5
−4.6
−5.9
−4.2
5.6
7.5
13.9
11.4
5.1
−2.9
−6.8
−11.2
−8.7
−3.4
−7.5
Shares out B
0.07
0.07
0.07
0.07
0.07
0.07
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.06
0.05
0.05
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
65 of 65
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed